Ovarian Cancer
Disease, Diagnosis, and Treatment
- 1st Edition - October 1, 2025
- Imprint: Academic Press
- Editors: Bhupendra G. Prajapati, Mehul Chorawala, Seema Jadav
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 3 5 3 6 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 3 5 3 7 - 2
By providing a comprehensive overview of current research findings, emerging therapies, and clinical practices, Ovarian Cancer: Disease, Diagnosis and Treatment is an invalu… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteBy providing a comprehensive overview of current research findings, emerging therapies, and clinical practices, Ovarian Cancer: Disease, Diagnosis and Treatment is an invaluable resource. It will not only enhance the understanding of ovarian cancer's complex biology among professionals but also guide them in applying this knowledge to improve patient outcomes The book delivers the key knowledge and information needs faced by the audience center around understanding the latest advances in the underlying pathogenesis and treatment of ovarian cancer. This encompasses a broad spectrum of requirements, from grasping the molecular and genetic factors driving ovarian cancer development to staying updated on the latest therapeutic strategies, including targeted therapies and immunotherapies. In 19 chapters Ovarian Cancer: Disease, Diagnosis and Treatment gives a timely and comprehensive coverage of advances in ovarian cancer therapy, particularly highlighting the development and utilization of Nanotheranostics technologies. This focus not only addresses a crucial and cutting-edge area of cancer treatment but also positions the book as a forward- thinking resource that delves into the potential of Nanotheranostics to revolutionize cancer diagnostics and therapy.
Ovarian Cancer: Disease, Diagnosis and Treatment targets a specialized audience within the medical and scientific community, focusing on obstetricians and gynecologists, oncologists, cancer researchers, and importantly, patients with ovarian cancer. This audience selection underscores the project's dual aim of advancing scientific knowledge and directly benefiting patient care in the realm of ovarian cancer, bridging the gap between research, clinical application, and patient advocacy.
Ovarian Cancer: Disease, Diagnosis and Treatment targets a specialized audience within the medical and scientific community, focusing on obstetricians and gynecologists, oncologists, cancer researchers, and importantly, patients with ovarian cancer. This audience selection underscores the project's dual aim of advancing scientific knowledge and directly benefiting patient care in the realm of ovarian cancer, bridging the gap between research, clinical application, and patient advocacy.
- Provides a comprehensive understanding of ovarian cancer
- Gives insight in the diagnostics and treatment strategies of ovarian cancer
- Describes the drugs used and novel formulation for targeting the treatment of ovarian cancer
Researchers working across the biosciences in the fields of oncology and gynecology
1. Understanding Ovarian Cancer
2. Epithelial Ovarian Cancer: The Most Common Subtype
3. Germ Cell Tumors: Ovarian Cancer in Young Women
4. Stromal Tumors: Exploring Rare Ovarian Cancer Types
5. Ovarian Oncosomes
6. Potential role of Microbiome in ovarian cancer
7. Early Detection Matters: Screening and Diagnostic Tools
8. Targeting Mitochondria for Treatment of Ovarian Cancer
9. Surgical Interventions: Reshaping the Battle against Ovarian Cancer
10. Natural Drugs for Ovarian Cancers
11. Novel Synthetic molecules for Ovarian Cancer
12. Chemotherapy: A Powerful Weapon in Ovarian Cancer Treatment
13. Radiation Therapy: Targeting Ovarian Cancer with Precision
14. Nanoparticles in treating Ovarian Cancer
15. Liposomes in treating Ovarian Cancer
16. Therapeutic Vaccines for Ovarian Cancer
17. The Genetic Puzzle: BRCA Mutations and Personalized Medicine
18. Life Beyond Treatment: Nurturing Survivorship
19. Monitoring for Recurrence: Follow-Up Care and Surveillance
2. Epithelial Ovarian Cancer: The Most Common Subtype
3. Germ Cell Tumors: Ovarian Cancer in Young Women
4. Stromal Tumors: Exploring Rare Ovarian Cancer Types
5. Ovarian Oncosomes
6. Potential role of Microbiome in ovarian cancer
7. Early Detection Matters: Screening and Diagnostic Tools
8. Targeting Mitochondria for Treatment of Ovarian Cancer
9. Surgical Interventions: Reshaping the Battle against Ovarian Cancer
10. Natural Drugs for Ovarian Cancers
11. Novel Synthetic molecules for Ovarian Cancer
12. Chemotherapy: A Powerful Weapon in Ovarian Cancer Treatment
13. Radiation Therapy: Targeting Ovarian Cancer with Precision
14. Nanoparticles in treating Ovarian Cancer
15. Liposomes in treating Ovarian Cancer
16. Therapeutic Vaccines for Ovarian Cancer
17. The Genetic Puzzle: BRCA Mutations and Personalized Medicine
18. Life Beyond Treatment: Nurturing Survivorship
19. Monitoring for Recurrence: Follow-Up Care and Surveillance
- Edition: 1
- Published: October 1, 2025
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780443335365
- eBook ISBN: 9780443335372
BP
Bhupendra G. Prajapati
Dr. Bhupendra G. Prajapati is Professor in the Department of Pharmaceutics at Shree S.K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India. An alumnus of Hemchandracharya North Gujarat University (Doctorate) and M.S. University of Baroda (B.Pharm and M.Pharm), he has over 22 years of experience in academia, research, and industry. Dr. Prajapati has received numerous accolades, including the AICTE's Career Award for Young Teacher and the President Award for Staff Excellence in Research and Capacity Building from Ganpat University. With over 80 national and international publications, he has secured various research grants and holds multiple patents in NDDS. He has supervised numerous Ph.D. and PG research scholars and delivered over 50 expert talks globally. As an editor of 10 international books and contributor of 70 book chapters, his research focuses on lipid-based drug delivery and nanotech formulations. Dr. Prajapati is an active member of IPA, APTI, and CRSIC.
Affiliations and expertise
Professor, Department of Pharmaceutics and Pharmaceutical Technology, Shree S.K. Patel College of Pharmaceutical Education & Research, Faculty of Pharmacy, Ganpat University, IndiaMC
Mehul Chorawala
Dr. Mehul R. Chorawala works as an assistant professor at L. M. College of Pharmacy, Ahmedabad, Gujarat, India. He is an alumnus of the University of Iowa, IA, USA (Postdoctoral Fellow). He has decades of academic and industry experience mainly focusing on research. He published more dozens of international and national peer reviewed publications along with several books. He is an active member of American Heart Association (AHA) and Indian Pharmacological Society. His current research focus is on immune-inflammation, oxidative-nitrosative stress, medical oncology, metabolic disorders such as diabetes mellitus and its complications.
Affiliations and expertise
Assistant Professor, L. M. College of Pharmacy, Ahmedabad, Gujarat, IndiaSJ
Seema Jadav
Ms.Seema Jadav works as a Clinical Pharmacist in the UK. She received her Bachelor’s degree in Pharmacy from S.P. University in India and Masters in Public Health degree from Curtin University, Australia. She then moved to the U.K where she registered as a pharmacist. She currently works in a General Practitioner surgery alongside doctors, nurses and other health care professionals. She previously worked as a mental health pharmacist in hospitals for eight years for patients with critical disease. Whilst in this role she also acquired a Post Graduate Certificate in Psychiatric Therapeutics. She is now going to work towards securing a prescribing qualification to become a pharmacist prescriber with special interest in mental health, cancer, diabetes and hypertension.
Affiliations and expertise
Sanofi Pharmaceutical